Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sterne

Showing results (571-580 of 669) with videos related to

Pageof 67
Sort By:
Lancet (London, England)|April 14, 2009
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies, Jonathan A C Sterne, Margaret May, et al.
BJGP Open|June 11, 2025
Patient characteristics associated with clinically coded long COVID: an OpenSAFELY study using electronic health recordsYinghui Wei, Elsie Mf Horne, Rochelle Knight, et al.
International Journal of Epidemiology|November 14, 2012
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristicsMargaret T May, Robert S Hogg, Amy C Justice, et al.
Plos One|February 16, 2017
Comparison of microbiological diagnosis of urinary tract infection in young children by routine health service laboratories and a research laboratory: Diagnostic cohort studyKate Birnie, Alastair D Hay, Mandy Wootton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 29, 2014
Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patientsSuzanne M Ingle, Margaret T May, M John Gill, et al.
Epidemiology (Cambridge, Mass.)|June 24, 2024
Effectiveness of mRNA COVID-19 Vaccines as First Booster Doses in England: An Observational Study in OpenSAFELY-TPPElsie M F Horne, William J Hulme, Edward P K Parker, et al.
Plos One|August 16, 2016
Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral TherapyAdam Trickey, Margaret T May, Janne Vehreschild, et al.
BMJ Open|September 12, 2023
Development of the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guidelineHarrison J Hansford, Aidan G Cashin, Matthew D Jones, et al.
AIDS (London, England)|February 18, 2015
Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients, Marie-Anne Vandenhende, Suzanne Ingle, et al.
AIDS (London, England)|September 4, 2025
The relationship of smoking and unhealthy alcohol use to HIV care retention and viral suppression: findings from a multi-site cohort studyDerek D Satre, Varada Sarovar, Tory Levine, et al.
Pageof 67

Showing results (571-580 of 669) with videos related to

Sort By:
Pageof 67
Lancet (London, England)|April 14, 2009
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies, Jonathan A C Sterne, Margaret May, et al.
BJGP Open|June 11, 2025
Patient characteristics associated with clinically coded long COVID: an OpenSAFELY study using electronic health recordsYinghui Wei, Elsie Mf Horne, Rochelle Knight, et al.
International Journal of Epidemiology|November 14, 2012
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristicsMargaret T May, Robert S Hogg, Amy C Justice, et al.
Plos One|February 16, 2017
Comparison of microbiological diagnosis of urinary tract infection in young children by routine health service laboratories and a research laboratory: Diagnostic cohort studyKate Birnie, Alastair D Hay, Mandy Wootton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 29, 2014
Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patientsSuzanne M Ingle, Margaret T May, M John Gill, et al.
Epidemiology (Cambridge, Mass.)|June 24, 2024
Effectiveness of mRNA COVID-19 Vaccines as First Booster Doses in England: An Observational Study in OpenSAFELY-TPPElsie M F Horne, William J Hulme, Edward P K Parker, et al.
Plos One|August 16, 2016
Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral TherapyAdam Trickey, Margaret T May, Janne Vehreschild, et al.
BMJ Open|September 12, 2023
Development of the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guidelineHarrison J Hansford, Aidan G Cashin, Matthew D Jones, et al.
AIDS (London, England)|February 18, 2015
Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients, Marie-Anne Vandenhende, Suzanne Ingle, et al.
AIDS (London, England)|September 4, 2025
The relationship of smoking and unhealthy alcohol use to HIV care retention and viral suppression: findings from a multi-site cohort studyDerek D Satre, Varada Sarovar, Tory Levine, et al.
Pageof 67